Prescription drug · ANDA
Doxercalciferol NDC 23155-539
Doxercalciferol 1 ug/1 · Capsule · Oral · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 23155-539-25 | 23155053925 | 50 CAPSULE in 1 BOTTLE (23155-539-25)Marketed from Oct 31, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Doxercalciferol
- Generic name (nonproprietary)
- doxercalciferol
- Active ingredients
- Doxercalciferol — 1 ug/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205360
- Marketing start
- Listing expires
- Other FDA classes
- Ergocalciferols (Chemical structure)
- Identifiers
- Product ID 23155-539_861e8a97-2618-40cd-b2bd-6b21cd9a38dbSPL ID 861e8a97-2618-40cd-b2bd-6b21cd9a38dbSPL set ID 2ed2f592-27a7-4c10-a18a-21a3f221d3b1RxCUI 310023, 406503, 858262UNII 3DIZ9LF5Y9
- Pharmacologic class
- Vitamin D2 Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N423155053925followed by a unit qualifier and the quantityPackage 23155-0539-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Doxercalciferol capsules are indicated for the treatment of secondary hyperparathyroidism in adult patients with Stage 3 or Stage 4 chronic kidney disease (CKD) and adult patients with CKD on dialysis. Doxercalciferol Capsules is a synthetic vitamin D 2 analog: Doxercalciferol capsules are indicated for the treatment of secondary hyperparathyroidism in adult patients with Stage 3 or Stage 4 chronic kidney disease (CKD) and adult patients with CKD on dialysis. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 205360
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Doxercalciferol | Doxercalciferol .5 ug/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-538 |
| Doxercalciferol | Doxercalciferol 2.5 ug/1 | CapsuleOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-540 |
| Doxercalciferol | Doxercalciferol .5 ug/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4642 |
| Doxercalciferol | Doxercalciferol 1 ug/1 | CapsuleOral | Chartwell RX, LLC | 62135-451 |
| Doxercalciferol | Doxercalciferol .5 ug/1 | CapsuleOral | Chartwell RX, LLC | 62135-450 |
| Doxercalciferol | Doxercalciferol 2.5 ug/1 | CapsuleOral | Chartwell RX, LLC | 62135-452 |